quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:32:02·25d
SECFiling
Unicycive Therapeutics Inc. logo

SEC Form 10-K filed by Unicycive Therapeutics Inc.

UNCY· Unicycive Therapeutics Inc.
Health Care
Original source

Companies

  • UNCY
    Unicycive Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Apr 21UpdateGuggenheim$6.00
  • Apr 4UpdatePiper Sandler$9.00
  • Aug 9UpdateRoth Capital$13.50

Related

  • PR15d
    Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
  • SEC18d
    SEC Form 8-K filed by Unicycive Therapeutics Inc.
  • SEC25d
    Unicycive Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR25d
    Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
  • SEC65d
    Amendment: SEC Form SCHEDULE 13G/A filed by Unicycive Therapeutics Inc.
  • SEC69d
    Amendment: SEC Form SCHEDULE 13G/A filed by Unicycive Therapeutics Inc.
  • SEC72d
    Amendment: SEC Form SCHEDULE 13G/A filed by Unicycive Therapeutics Inc.
  • PR79d
    Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim's Emerging Outlook: Biotech Summit
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022